Edit
Solace Therapeutics
https://www.solacetx.com/index.htmlLast activity: 22.03.2021
Probably Closed
Stress Urinary Incontinence (SUI), the most prevalent form of incontinence among women, affects an estimated 15 million adult women in the U.S. Most women believe that it is a normal part of aging. These women choose to manage their SUI by utilizing absorbent products such as protective pads versus seeking medical help. Solace is dedicated to improving the quality of life for women whose daily life is disrupted by their incontinence.
Location: United States, Massachusetts, Framingham
Employees: 11-50
Phone: +1 508-283-1200
Founded date: 2002
Investors 3
| Date | Name | Website |
| - | New Enterp... | nea.com |
| - | S3 Venture... | s3vc.com |
| - | Questa Cap... | questacapi... |
Mentions in press and media 4
| Date | Title | Description |
| 22.03.2021 | Solace Therapeutics Announces That Scripps Health Enrolls First Patient in US Pivotal Clinical Trial, Using New Office-Based Treatment for Female Stress Urinary Incontinence(SUI) | SAN DIEGO--(BUSINESS WIRE)--Mar 22, 2021-- Scripps Health, has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR Clinical Trial is being conducted in several distinguished clinics throughout the US to test the safety and... |
| 26.08.2015 | Solace Therapeutics Completes Enrollment of the SUCCESS Clinical Trial for the Vesair® Bladder Control System for Stress Urinary Incontinence | FRAMINGHAM, Mass.–(BUSINESS WIRE)–August 26, 2015– Solace Therapeutics, a medical technology company focused on developing breakthrough treatments for urinary incontinence, today announced that it has completed enrollment in the SUCCESS (St... |
| 28.03.2012 | Solace Therapeutics Closes $7M | FRAMINGHAM, MA, Firm that develops non-surgical treatments for common bladder disorders, has raised $7 million in equity financing. >> Click here for more funding data on Solace Therapeutics >> To export Solace Therapeutics ... |
| - | Solace Therapeutics Announces that Urology of San Antonio Enrolls First Patient in US Pivotal Clinical Trial, using New Office-Based Treatment for Female Stress Urinary Incontinence(SUI). | SAN ANTONIO--(BUSINESS WIRE)--Mar 22, 2021-- Urology of San Antonio, has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR Clinical Trial is being conducted in several distinguished clinics throughout the US to test the ... |